Rigor prophylaxis in stage IV melanoma and renal cell carcinoma patients treated with high dose IL-2.
BMC Cancer
; 18(1): 1007, 2018 Oct 20.
Article
in En
| MEDLINE
| ID: mdl-30342473
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Renal Cell
/
Interleukin-2
/
Fever
/
Kidney Neoplasms
/
Melanoma
/
Antineoplastic Agents
Type of study:
Diagnostic_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
BMC Cancer
Journal subject:
NEOPLASIAS
Year:
2018
Document type:
Article
Affiliation country:
United States
Country of publication:
United kingdom